Multiplelines of evidence implicate breast cancer development and progression as underthe control of steroid hormones, in particular estrogens, via their interactionwith estrogen receptors (ERs) and cross-talk of ER with receptors includingEGFR [16–18]. The gene discussed is EREG; the disease is breast carcinoma.